Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, PARTNERSHIPS

KFSH&RC Announced as Strategic Partner for the Saudi American Healthcare Forum 2024



RIYADH, Saudi Arabia, April 23, 2024 (GLOBE NEWSWIRE) -- KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the American and Arab populations and to support collaboration, innovation, and healthcare partnerships between the two nations.

The forum will focus on key topics that contribute to the development of healthcare, in addition to creating a platform for bilateral information exchange, exploring cooperation opportunities, and sharing best practices in global healthcare. It also aims to foster relations in the health sector between the two sides and stimulate investment in health tourism.

Within the sessions held at the Saudi American Healthcare Forum, Dr. Abdulaziz Al Rajhi, Chief Medical Officer at KFSH&RC, will participate in a breakout session on "Time Critical Investments to Advance Medical Tourism, Health & Business in the Middle East". Dr. Edward Cupler, Executive Director for Research and Innovation at KFSH&RC, will discuss "Investing in Saudi Arabia's Biotech Sector". Additionally, Dr. Khaled Abu Khabar, Chairman of the Molecular Biomedicine Department and a Principal Scientist at KFSH&RC, will partake in a panel session titled "Private Investment and Academic Medicine as an Innovative and Disruptive Power Couple".

The Saudi American Healthcare Forum will feature a broad attendance, including top businessmen, academics, and industry experts from both countries, to enhance initiatives and solutions, and support the existing bilateral relations based on "Healthcare Diplomacy".

It is noteworthy that KFSH&RC has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 healthcare institutions for the second consecutive year, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best hospitals by the prestigious Newsweek magazine.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, "Brand Finance" ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally. Additionally, in 2024, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

For more information please contact:

Mr. Essam Al-Zahrani, Acting Media Affairs Head, 0555254429

Mr. Abdullah Alown, Senior Media Affairs Editor, 0556294232

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/47dee191-5576-442d-b65a-88374feaeb96



These press releases may also interest you

at 04:15
During its annual event "BIG UP", French Tech Saint-Etienne Lyon awarded the BIG Start-up of the Year trophy, honoring a start-up that exemplifies the region's innovation and richness. French Tech Saint-Etienne Lyon, a non-profit association...

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...



News published on and distributed by: